Detecting diseases through body odor? New laser technology shows potential for non-invasive diagnostics

Researchers from the Fraunhofer Institute for Integrated Circuits and the Technical University of Dresden have developed a new laser-based technology for detecting disease-related changes in body odor through a process called photoacoustic spectroscopy. This innovative method analyzes volatile organic compounds (VOCs) in simple body swabs to identify characteristic odor patterns associated with various diseases, such as Parkinson's disease, COVID-19, and other medical conditions.

An initial study involving 24 participants, including healthy controls and individuals with Parkinson's disease, COVID-19, and other conditions, revealed differences in VOC signatures between the samples. Nasal swabs were found to be particularly promising in capturing these disease-specific patterns, although further research is needed to confirm the stability of the results over time.

The technology utilizes widely tunable quantum cascade lasers and a highly sensitive photoacoustic detector to generate a unique spectral fingerprint of the VOCs. This spectral fingerprint allows for a significant reduction in measurement scope without compromising the accuracy of the data. The compact, fast, and cost-effective nature of this measurement technique could pave the way for the development of a non-invasive diagnostic tool for early disease detection.

However, it is important to note that this proof-of-concept study was conducted under controlled laboratory conditions and not intended to replace medical diagnoses. Larger, more diverse studies involving real-world conditions will be necessary before the technology can be implemented in clinical settings. Despite this, the researchers believe that the technology has the potential to provide early indications of potential diseases, supporting decisions about further testing and ultimately improving patient care.